Related Experiment Video
Updated: Jul 16, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes
Issam Zineh1, Amber L Beitelshees, Michael J Haller
1Department of Pharmacy Practice and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, Florida, USA.
Insights
Genetic variations in the NOS3 gene are linked to arterial stiffness in children with type 1 diabetes. The -786T-->C polymorphism showed a significant association, suggesting a potential role in cardiovascular risk assessment.
Area of Science:
- Cardiovascular Research
- Genetics
- Pediatric Endocrinology
Background:
- Type 1 diabetes (T1D) is linked to endothelial dysfunction, arterial stiffness, and increased cardiovascular disease (CVD) risk.
- Previous studies showed increased arterial stiffness in children with T1D, unexplained by traditional CVD risk factors.
- Significant variation in arterial stiffness exists within pediatric T1D populations.
Purpose of the Study:
- To investigate the association between NOS3 gene polymorphisms and arterial stiffness in children with T1D.
- To explore potential genetic contributors to the variability of arterial stiffness observed in this population.
Main Methods:
- Studied 36 children (aged 10-21) with T1D undergoing radial tonometry.
- Measured arterial stiffness using corrected augmentation index (AI75).
- Determined genotypes for NOS3 -786T-->C and Glu298-->Asp polymorphisms via pyrosequencing; compared AI75 values by genotype using ANOVA and multivariate analysis.
Main Results:
- A significant difference in AI75 was found between -786TT and -786C carriers (P=0.01).
- No significant difference in AI75 was observed between Glu298Glu and Asp298 carriers (P=0.59).
- Univariate analysis identified age, sex, BMI percentile, and the -786T-->C genotype as significantly associated with AI75. A multivariate model including these factors was also significant (P=0.002, R2=0.40).
Conclusions:
- This study reports the first association between the NOS3 -786T-->C polymorphism and arterial stiffness in pediatric type 1 diabetes.
- These findings suggest a potential genetic influence on arterial stiffness in T1D.
- Larger studies are warranted to confirm these results for potential application in CVD risk assessment.
Objective:
Type 1 diabetes is associated with endothelial dysfunction, arterial stiffness, and an increased risk of cardiovascular disease (CVD) events. We previously demonstrated increased arterial stiffness in children with type 1 diabetes compared with control subjects. However, traditional CVD risk factors did not explain the difference in arterial stiffness. Furthermore, children with type 1 diabetes displayed notable within-group variation in arterial stiffness. We hypothesized that polymorphisms in the NOS3 gene may be associated with the differences seen in arterial stiffness within the population of children with type 1 diabetes.
Research Design And Methods:
Thirty-six consecutively enrolled subjects aged 10-21 years with type 1 diabetes were studied. Subjects underwent radial tonometry in a fasting state. A corrected augmentation index (AI75) was the primary measure of arterial stiffness. Genotypes were determined for the NOS3 -786T-->C and Glu298-->Asp polymorphisms by pyrosequencing. AI75 values by genotype groups were compared by ANOVA and multivariate analysis.
Results:
Median (interquartile range) AI75 values for -786TT and -786C carriers were -3.5 (-8.8 to 2.3) and 11.0 (6.0 to 14.4), respectively (P = 0.01); AI75 values for Glu298Glu patients and Asp298 carriers were 2.3 (-4.0 to 13.0) and 7.3 (-2.0 to 11.5), respectively (P = 0.59). In univariate analysis, age, sex, BMI percentile, and -786T-->C genotype were significantly associated with AI75. The multivariate model, which included these four variables, was significantly associated with AI75 (P = 0.002, R2 = 0.40).
Conclusions:
This is the first reported association between -786T-->C and arterial stiffness in type 1 diabetes. Larger studies are needed to confirm this observation for potential translation to risk assessment.
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational